Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00386035 · ClinicalTrials.gov registry record
Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study Participants
A clinical trial of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 883
- Enrollment target
- 20
- Study locations
NCT00386035: Completed study of HIV Infections, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00386035 is a study of HIV Infections that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 883 participants, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (99% higher). The trial reports 20 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00386035, a study of HIV Infections, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 883 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to compare the effects of two different anti-HIV drug regimens on HIV transmission risk behavior among SMART study participants.
Conditions Studied
Interventions
- DRUG Delayed ART
- DRUG Continuous ART
Study Locations (20)
California
- AIDS Healthcare Foundation CRS - Beverly Hills
- UCSF, Fresno, School of Medicine, Dept. of Internal Medicine CRS - Fresno
- Dr. M. Estes Med. Practice CRS - Mill Valley
- Dr. Robert Scott Med. Practice CRS - Oakland
- East Bay AIDS Ctr. CRS - Oakland
- Dr. Shawn Hassler Med. Practice CRS - San Francisco
- Positive Health Program Clinic (San Francisco Gen. Hosp.) CRS - San Francisco
- Dr. Virginia Cafaro Med. Practice CRS - San Francisco
- Dr. William Owen Med. Practice CRS - San Francisco
- Castro-Mission Health Ctr. CRS - San Francisco
- San Francisco VAMC, Infectious Diseases Clinic CRS - San Francisco
- UCSF PHP, Gen. Internal Medicine Practice CRS - San Francisco
Colorado
- Beacon Clinic at Boulder CRS - Boulder
- Denver Infectious Diseases Consultants CRS - Denver
- Kaiser Permanente of Denver CRS - Denver
- Univ. of Colorado Health Science Ctr. CRS - Denver
- Denver Public Health CRS - INSIGHT - Denver
- Denver Public Health CRS - Denver
- Eastside Family Health Ctr. CRS - Denver
- Denver VAMC CRS - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 883 participants |
| Start Date | 2002-01 |
| Est. Completion | 2008-09 |
What the finished NCT00386035 record still lists
NCT00386035 is an observational study that tracks outcomes without assigning an intervention. The registered 883 participants enrollment target is mid-sized for trials with a published cap, above the 444-participant average among 542 other HIV Infections trials with a reported enrollment target (99% higher).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Delayed ART is the first listed.
NCT00386035 names 20 study sites across 2 states, led by California, Colorado.
Frequently Asked Questions
What is clinical trial NCT00386035 about?
NCT00386035 is a clinical study titled "Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study Participants". The purpose of this study is to compare the effects of two different anti-HIV drug regimens on HIV transmission risk behavior among SMART study participants.
What is the current status of trial NCT00386035?
This trial is currently completed. The enrollment target is 883 participants. The study started on 2002-01. Estimated completion is 2008-09.
What conditions does trial NCT00386035 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT00386035?
The interventions under investigation include: Delayed ART (DRUG), Continuous ART (DRUG).
Who is sponsoring clinical trial NCT00386035?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00386035 being conducted?
This trial has 20 study locations across California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00386035's enrollment target sits among peer trials
883 34th of 542 higher than 509 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07196748 · 882 participants · Phase 3
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
- NCT05525663 · 880 participants · NA
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia